Bioventus director receives RSU grant, exercises awards
Bioventus Inc. director Michelle McMurry-Heath reported equity compensation and a vesting event.
Rhea-AI Filing Summary
Bioventus Inc. director Michelle McMurry-Heath reported equity compensation and a vesting event. On June 2, 2026, 32,282 restricted stock units were exercised and converted into the same number of shares of Class A common stock, leaving her with 77,279 shares held directly. Each RSU represents a contingent right to receive one share of Class A common stock, and the RSUs referenced in the footnotes vest based on service on the Board and the timing of the company’s annual stockholder meeting. On June 3, 2026, she also received a grant of 25,146 RSUs as additional equity compensation, which will vest according to the disclosed schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,146 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 32,282 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 32,282 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- F2. The RSUs vested on June 2, 2026.
- F3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Key Figures
Key Terms
Restricted Stock Units financial
Class A common stock financial
vested financial
Annual Meeting of Stockholders financial
Board of Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Bioventus (BVS) disclose for Michelle McMurry-Heath?
What RSU grant did Bioventus (BVS) report for Michelle McMurry-Heath on June 3, 2026?
How do the RSUs reported for Bioventus (BVS) director Michelle McMurry-Heath vest?
What happened to the previously outstanding Bioventus (BVS) RSUs that vested on June 2, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.